A systematic review with meta-analysis compared single- versus multi-port robotic approaches in prostate and renal surgery.

Researchers sought to determine whether survival outcomes for patients with early breast cancer was better with NACT or ACT when pCR was not achieved.

The approval for HR-SMM was based on data from the phase 3 AQUILA study, which evaluated Darzalex Faspro in adults aged 31 years and older with HR-SMM.

Researchers sought to determine whether zanubrutinib would be effective for patients with CLL/SLL who were intolerant to other BTK inhibitors.

Study reveals 5.05 percent of individuals carry pathogenic/likely pathogenic variants in in large, unselected U.S. population.